Peer-reviewedCC BYClinical and translational allergy
Is It Safe to Reduce Inhaled Corticosteroid Dose in Severe Asthma Patients Receiving Biologic Therapy?
- 1Ankara Bilkent City Hospital
Related
- From Quiet Asthma to Clinical Remission: Can Optimized Maximal Inhaled Therapy Achieve Biologic-Free Remission in Difficult-to-Treat and Severe Asthma?
- Long-Term Inhaled Corticosteroid Use and the Risk of Open-Angle Glaucoma in Patients with Chronic Obstructive Pulmonary Disease.
- Corticosteroid Burden and Hearing Outcomes in Eosinophilic Otitis Media with and without Biologic Therapy: A Pilot Retrospective Cohort Study.
- Disease Knowledge Assessed by RAKE-T and Its Sociodemographic and Clinical Correlates in Patients with Rheumatoid Arthritis Receiving Biologic and Targeted Synthetic DMARDs: A Multicenter Cross-Sectional Study
- Predictors of Response to Corticosteroid Therapy in Idiopathic Granulomatous Mastitis: A Retrospective Cohort Study of 176 Patients
BibTeX
@article{ozer2026safe,
title = {{Is It Safe to Reduce Inhaled Corticosteroid Dose in Severe Asthma Patients Receiving Biologic Therapy?}},
author = {Nagihan Orhan Özer and Betül Özdel Öztürk and Begüm Görgülü Akın and Ceren Kaplankıran and Şadan Soyyiğit},
journal = {Clinical and translational allergy},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13691418},
note = {CC BY},
}
RIS
TY - JOUR
TI - Is It Safe to Reduce Inhaled Corticosteroid Dose in Severe Asthma Patients Receiving Biologic Therapy?
AU - Nagihan Orhan Özer
AU - Betül Özdel Öztürk
AU - Begüm Görgülü Akın
AU - Ceren Kaplankıran
AU - Şadan Soyyiğit
PY - 2026
DA - 2026/10/01
JO - Clinical and translational allergy
UR - https://europepmc.org/article/PMC/PMC13691418
SN - 2045-7022
ER -